The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSkinbiotherap. Regulatory News (SBTX)

Share Price Information for Skinbiotherap. (SBTX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 10.00
Bid: 9.50
Ask: 10.50
Change: 0.00 (0.00%)
Spread: 1.00 (10.526%)
Open: 10.15
High: 10.15
Low: 9.75
Prev. Close: 10.00
SBTX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

9 Jun 2017 10:38

RNS Number : 6698H
SkinBioTherapeutics PLC
09 June 2017
 

TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi

1. Identity of the issuer or the underlying issuerof existing shares to which voting rights areattached: ii

SkinBioTherapeutics

2 Reason for the notification (please tick the appropriate box or boxes):

An acquisition or disposal of voting rights

YES

An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached

NO

An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments

NO

An event changing the breakdown of voting rights

NO

Other (please specify):

3. Full name of person(s) subject to thenotification obligation: iii

SPREADEX LTD

4. Full name of shareholder(s)  (if different from 3.):iv

5. Date of the transaction and date onwhich the threshold is crossed orreached: v

30/05/2017

6. Date on which issuer notified:

08/06/2017

7. Threshold(s) that is/are crossed orreached: vi, vii

 

8. Notified details:

A: Voting rights attached to shares viii, ix

Class/type ofshares

if possible usingthe ISIN CODE

Situation previousto the triggeringtransaction

Resulting situation after the triggering transaction

NumberofShares

NumberofVotingRights

Numberof shares

Number of votingrights

% of voting rights x

Direct

Direct xi

Indirect xii

Direct

Indirect

Ordinary 1 -

3,233,333

3,233,333

2,933,333

2,933,333

2.47%

GB00BF33H870

B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financialinstrument

Expirationdate xiii

Exercise/Conversion Period xiv

Number of votingrights that may beacquired if theinstrument isexercised/ converted.

% of votingrights

CFD/SPREADBET

501,445

0.42%

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi

Resulting situation after the triggering transaction

Type of financialinstrument

Exercise price

Expiration date xvii

Exercise/Conversion period xviii

Number of voting rights instrument refers to

 

% of voting rights xix, xx

 

 

 

Nominal

Delta

Total (A+B+C)

Number of voting rights

Percentage of voting rights

3,434,778

2.89%

 

9. Chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held, if applicable: xxi

 

 

Proxy Voting:

10. Name of the proxy holder:

11. Number of voting rights proxy holder will ceaseto hold:

12. Date on which proxy holder will cease to holdvoting rights:

13. Additional information:

14. Contact name:

DAVID CORBEN

15. Contact telephone number:

01727 895135

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLFLMLTMBJMMFR
Date   Source Headline
4th Jan 20231:33 pmRNSResult of General Meeting
30th Dec 202211:33 amRNSResults of AGM
23rd Dec 20227:00 amRNSReport and Accounts, and Provision Update
21st Dec 20227:00 amRNSResult of Retail Offer
19th Dec 202211:15 amEQSSkinBioTherapeutics will 'continue to be flexible enough to adapt to opportunities'
16th Dec 20227:00 amRNSResult of Placing
15th Dec 20224:32 pmRNSREX Retail Offer
15th Dec 20224:31 pmRNSPlacing and REX Retail Offer
15th Dec 20224:30 pmRNSFinal Results
6th Dec 20227:40 amRNSNotice of AGM
31st Aug 20222:05 pmRNSSecond Price Monitoring Extn
31st Aug 20222:00 pmRNSPrice Monitoring Extension
31st Aug 20227:00 amRNSUpdate of oral programme and trading
22nd Aug 20229:05 amRNSSecond Price Monitoring Extn
22nd Aug 20229:00 amRNSPrice Monitoring Extension
27th Jul 20224:41 pmRNSSecond Price Monitoring Extn
27th Jul 20224:36 pmRNSPrice Monitoring Extension
27th Jul 20222:05 pmRNSSecond Price Monitoring Extn
27th Jul 20222:00 pmRNSPrice Monitoring Extension
13th Jun 20223:37 pmRNSStmnt re Share Price Movement
13th Jun 202211:05 amRNSSecond Price Monitoring Extn
13th Jun 202211:00 amRNSPrice Monitoring Extension
26th May 20222:02 pmRNSChange of Registered Office
27th Apr 20227:00 amRNSConfirmation of Directorate Appointments
29th Mar 202211:05 amRNSSecond Price Monitoring Extn
29th Mar 202211:00 amRNSPrice Monitoring Extension
29th Mar 20227:00 amRNSHalf-year Report
28th Mar 20227:00 amRNSDirectorate Change
22nd Mar 20222:00 pmRNSInvestor Presentation – Interim Financial Results
16th Mar 20227:00 amRNSNotice of Results
17th Feb 20227:00 amRNSBusiness update
8th Feb 202211:20 amRNSHolding(s) in Company
18th Jan 20227:00 amRNSDirectorate Change
12th Jan 20227:00 amRNSGrant of share options
23rd Dec 20212:00 pmRNSResult of AGM
21st Dec 20212:00 pmRNSAnnual General Meeting 2021 – Change of Venue
14th Dec 20217:00 amRNSHolding(s) in Company
6th Dec 20212:05 pmRNSSecond Price Monitoring Extn
6th Dec 20212:00 pmRNSPrice Monitoring Extension
30th Nov 20214:41 pmRNSSecond Price Monitoring Extn
30th Nov 20214:36 pmRNSPrice Monitoring Extension
30th Nov 20212:05 pmRNSSecond Price Monitoring Extn
30th Nov 20212:00 pmRNSPrice Monitoring Extension
30th Nov 202111:06 amRNSSecond Price Monitoring Extn
30th Nov 202111:00 amRNSPrice Monitoring Extension
30th Nov 20217:00 amRNSFull year results
26th Nov 20214:12 pmRNSNotice of Results
15th Nov 20214:59 pmRNSHolding(s) in Company
15th Nov 20217:00 amRNSPlacing of Shares
29th Oct 20214:40 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.